title: Commentary: management of the patient.
authors.affiliation: Melanoma Unit, Royal Marsden Hospital, London.
authors.forename: S R
authors.initials: SR
authors.lastname: Johnston
authors.forename: K
authors.initials: K
authors.lastname: Broadley
authors.forename: G
authors.initials: G
authors.lastname: Henson
authors.forename: C
authors.initials: C
authors.lastname: Fisher
authors.forename: M
authors.initials: M
authors.lastname: Henk
authors.forename: M E
authors.initials: ME
authors.lastname: Gore
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use*; D003657:Decision Making; D004992:Ethics, Medical; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome; D013125:Spinal Neoplasms / Q000188:drug therapy* / Q000556:secondary*
chemical_list: D000970:Antineoplastic Agents; D003606:Dacarbazine